title: Medication use in patients presenting to a rural and remote memory clinic.
authors.forename: Trevor A
authors.initials: TA
authors.lastname: Steve
authors.forename: Andrew
authors.initials: A
authors.lastname: Kirk
authors.forename: Margaret
authors.initials: M
authors.lastname: Crossley
authors.forename: Debra
authors.initials: D
authors.lastname: Morgan
authors.forename: Carl
authors.initials: C
authors.lastname: D'Arcy
authors.forename: Jay
authors.initials: J
authors.lastname: Biem
authors.forename: Dorothy
authors.initials: D
authors.lastname: Forbes
authors.forename: Norma
authors.initials: N
authors.lastname: Stewart
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000544:Alzheimer Disease / Q000175:diagnosis* / Q000188:drug therapy* / Q000503:physiopathology; D001569:Benzodiazepines / Q000008:administration & dosage / Q000009:adverse effects; D018680:Cholinergic Antagonists / Q000008:administration & dosage* / Q000009:adverse effects; D005260:Female; D006801:Humans; D008297:Male; D008569:Memory Disorders / Q000175:diagnosis* / Q000188:drug therapy* / Q000503:physiopathology; D008875:Middle Aged; D017063:Outcome Assessment, Health Care; D019114:Remote Consultation / Q000379:methods; D019035:Rural Health Services / Q000706:statistics & numerical data; D012525:Saskatchewan; D017216:Telemedicine / Q000379:methods*; D016896:Treatment Outcome
chemical_list: D018680:Cholinergic Antagonists; D001569:Benzodiazepines